Amedisys Inc (AMED)
Debt-to-capital ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 1,134,540 | 1,147,760 | 1,125,200 | 1,088,180 | 1,066,510 | 1,039,910 | 1,006,780 | 1,079,120 | 1,051,570 | 1,015,740 | 985,646 | 966,758 | 931,351 | 905,264 | 874,272 | 788,153 | 809,224 | 756,205 | 720,851 | 679,197 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,134,540K)
= 0.00
Amedisys Inc has consistently maintained a debt-to-capital ratio of 0.00 for the periods spanning from March 31, 2020, to December 31, 2024. This implies that the company has not utilized any debt in relation to its capital structure during this time frame. A debt-to-capital ratio of 0.00 indicates that the company's capital is entirely sourced from equity rather than debt financing. This may suggest a conservative financial approach, as the absence of debt can lower financial risk and interest expenses for the company. However, it is essential to note that while a low debt-to-capital ratio can be positive, it may also indicate limited access to debt-based funding for potential growth or investment opportunities. Overall, the consistent 0.00 debt-to-capital ratio reflects Amedisys Inc's stable financial position and prudent capital structure management throughout the analyzed period.
Peer comparison
Dec 31, 2024